SAQA All qualifications and part qualifications registered on the National Qualifications Framework are public property. Thus the only payment that can be made for them is for service and reproduction. It is illegal to sell this material for profit. If the material is reproduced or quoted, the South African Qualifications Authority (SAQA) should be acknowledged as the source.
SOUTH AFRICAN QUALIFICATIONS AUTHORITY 
REGISTERED UNIT STANDARD: 

Explain the Medicines and Related Substances Control Amendment Act, 59 of 2002, as it impacts on medical schemes 
SAQA US ID UNIT STANDARD TITLE
243149  Explain the Medicines and Related Substances Control Amendment Act, 59 of 2002, as it impacts on medical schemes 
ORIGINATOR
SGB Insurance and Investment 
PRIMARY OR DELEGATED QUALITY ASSURANCE FUNCTIONARY
-  
FIELD SUBFIELD
Field 03 - Business, Commerce and Management Studies Finance, Economics and Accounting 
ABET BAND UNIT STANDARD TYPE PRE-2009 NQF LEVEL NQF LEVEL CREDITS
Undefined  Regular  Level 4  NQF Level 04 
REGISTRATION STATUS REGISTRATION START DATE REGISTRATION END DATE SAQA DECISION NUMBER
Reregistered  2018-07-01  2023-06-30  SAQA 06120/18 
LAST DATE FOR ENROLMENT LAST DATE FOR ACHIEVEMENT
2024-06-30   2027-06-30  

In all of the tables in this document, both the pre-2009 NQF Level and the NQF Level is shown. In the text (purpose statements, qualification rules, etc), any references to NQF Levels are to the pre-2009 levels unless specifically stated otherwise.  

This unit standard replaces: 
US ID Unit Standard Title Pre-2009 NQF Level NQF Level Credits Replacement Status
113932  Explain the Medicines and Related Substances Control Amendment Act, 59 of 2003, as it impacts on medical schemes  Level 4  NQF Level 04  Complete 

PURPOSE OF THE UNIT STANDARD 
This Unit Standard is intended for learners in a medical scheme environment. It will add value to Administrators, Trainee Healthcare Intermediaries, Product Developers, Coordinators of Medical Schemes, Call Centre Agents, Trainee Financial Planners, Principal Officers and Trustees of Medical Schemes learners in Medical Risk Units, Disease and Case Managers and Medical Claims Assessors.

The qualifying learner is capable of:
  • Explaining the purpose of the Medicines and Related Substances Control Amendment Act, 59 of 2002.
  • Analysing the impact of the Act on the pricing of medicines and controlled substances.
  • Analysing the implications of the Medicines and Related Substances Control Amendment Act, 59 of 2002 for the supply of medicines and controlled substances.
  • Explaining the impact of the Act on service providers.
  • Analysing the major impact of the Act on medical schemes. 

  • LEARNING ASSUMED TO BE IN PLACE AND RECOGNITION OF PRIOR LEARNING 
    It is assumed that learners are competent in Communication and Mathematical Literacy at Level 3. 

    UNIT STANDARD RANGE 
    The typical scope of this Unit Standard is:
  • The Medicines and Related Substances Control Amendment Act, 59 of 2002.
  • Impact on group medical schemes.
  • Annexure A of the Medical Schemes Act.
  • The medicines and related controlled substances' supply chain includes, but is not limited to, manufacturers, importers, distributors, pharmacies, courier pharmacies and cross counter pharmacies.
  • Dispensing persons include, but are not limited to, doctors, nurses, dentists and pharmacists. 

  • Specific Outcomes and Assessment Criteria: 

    SPECIFIC OUTCOME 1 
    Explain the purpose of the Medicines and Related Substances Control Amendment Act, 59 of 2002. 

    ASSESSMENT CRITERIA
     

    ASSESSMENT CRITERION 1 
    Reasons for the introduction of the Act are explained with reference to the supply chain and the impact on profit margins. 

    ASSESSMENT CRITERION 2 
    The implications of the Act for the private sector are explained with examples. 

    ASSESSMENT CRITERION 3 
    The relationship between the Medical Schemes Act and the Medicines and Related Substances Control Amendment Act is explained with reference to the supply and pricing of medicines and controlled substances. 

    SPECIFIC OUTCOME 2 
    Analyse the impact of the Act on the pricing of medicines and controlled substances. 

    ASSESSMENT CRITERIA
     

    ASSESSMENT CRITERION 1 
    The concept of a single exit price is explained with examples. 

    ASSESSMENT CRITERION 2 
    The role of the Pricing Committee is explained and an indication is given of how the committee determines the exit price of medicines and controlled substances. 

    ASSESSMENT CRITERION 3 
    The impact of the Act on the supply chain of medicines and controlled substances is explained with examples. 

    ASSESSMENT CRITERION 4 
    The State tender price and single exit price are compared and an indication is given of the disparities between the two. 

    SPECIFIC OUTCOME 3 
    Analyse the implications of the Act for the supply of medicines and controlled substances. 

    ASSESSMENT CRITERIA
     

    ASSESSMENT CRITERION 1 
    The difference between a generic and a patent drug is explained and an indication is given as to why generics are cheaper. 

    ASSESSMENT CRITERION 2 
    The implications of the Act for the medicines and related controlled substances' supply chain are explained with reference to dispensing persons. 

    ASSESSMENT CRITERION 3 
    The implications of the Act for medicine outlets are explained with examples. 

    SPECIFIC OUTCOME 4 
    Explain the impact of the Act on service providers. 

    ASSESSMENT CRITERIA
     

    ASSESSMENT CRITERION 1 
    The concept of a professional fee is explained and an indication is given of the advantages and disadvantages of a set fee. 

    ASSESSMENT CRITERION 2 
    The impact of the Act on dispensing doctors is explained with examples. 

    SPECIFIC OUTCOME 5 
    Analyse the major impact of the Act on medical schemes. 

    ASSESSMENT CRITERIA
     

    ASSESSMENT CRITERION 1 
    The impact of prescribed minimum benefits on medical schemes is explained with examples. 

    ASSESSMENT CRITERION 2 
    The role of the State in the provision of minimum benefits is explained and an indication is given of the relationship between State facilities and medical schemes. 

    ASSESSMENT CRITERION 3 
    The implications of the chronic disease list for medical schemes are explained with reference to the structuring of formularies, preferred provider networks and the State tender price. 

    ASSESSMENT CRITERION 4 
    The impact of the Act on affordability is explained with reference to medicines and services. 


    UNIT STANDARD ACCREDITATION AND MODERATION OPTIONS 
  • Anyone assessing a candidate against this Unit Standard must be registered as an assessor with the relevant ETQA or ETQA where a Memorandum of Understanding (MOU) exists with the relevant ETQA.
  • Any institution offering learning that will enable achievement of this Unit Standard must be accredited as a provider through the relevant ETQA or ETQA where a Memorandum of Understanding (MOU) exists with the relevant ETQA.
  • Moderation of assessment will be overseen by the relevant ETQA according to the moderation guidelines and the agreed ETQA procedures. 

  • UNIT STANDARD ESSENTIAL EMBEDDED KNOWLEDGE 
    N/A 

    UNIT STANDARD DEVELOPMENTAL OUTCOME 
    N/A 

    UNIT STANDARD LINKAGES 
    N/A 


    Critical Cross-field Outcomes (CCFO): 

    UNIT STANDARD CCFO COLLECTING 
    The learner is capable of collecting, organising and critically evaluating information in analysing the implications of the Act for pricing, supply of medicines and controlled substances, service providers and medical schemes. 

    UNIT STANDARD ASSESSOR CRITERIA 
    N/A 

    REREGISTRATION HISTORY 
    As per the SAQA Board decision/s at that time, this unit standard was Reregistered in 2012; 2015. 

    UNIT STANDARD NOTES 
    This unit standard replaces unit standard 113932, " Explain the Medicines and Related Substances Control Amendment Act, 59 of 2003, as it impacts on medical schemes ", Level 4, 2 credits. 

    QUALIFICATIONS UTILISING THIS UNIT STANDARD: 
      ID QUALIFICATION TITLE PRE-2009 NQF LEVEL NQF LEVEL STATUS END DATE PRIMARY OR DELEGATED QA FUNCTIONARY
    Elective  66613   Further Education and Training Certificate: Wealth Management  Level 4  NQF Level 04  Reregistered  2021-06-30  As per Learning Programmes recorded against this Qual 


    PROVIDERS CURRENTLY ACCREDITED TO OFFER THIS UNIT STANDARD: 
    This information shows the current accreditations (i.e. those not past their accreditation end dates), and is the most complete record available to SAQA as of today. Some Primary or Delegated Quality Assurance Functionaries have a lag in their recording systems for provider accreditation, in turn leading to a lag in notifying SAQA of all the providers that they have accredited to offer qualifications and unit standards, as well as any extensions to accreditation end dates. The relevant Primary or Delegated Quality Assurance Functionary should be notified if a record appears to be missing from here.
     
    1. African Resources & Financial Training (Pty) Ltd 
    2. CKP Development Agency (Pty) Ltd. 
    3. De Vries Management & Training Services cc 
    4. Faisit (Pty) Ltd 
    5. Masifunde Training Centre (Pty) Ltd 
    6. Ray Strodl Consulting (Pty) Ltd 
    7. RJM Educational Consulting (Pty) Ltd 
    8. Sanlam Life Insurance Ltd 



    All qualifications and part qualifications registered on the National Qualifications Framework are public property. Thus the only payment that can be made for them is for service and reproduction. It is illegal to sell this material for profit. If the material is reproduced or quoted, the South African Qualifications Authority (SAQA) should be acknowledged as the source.